Hepatic Mitochondria and Insulin Resistance in Fatty Liver and Type 2 Diabetes
脂肪肝和 2 型糖尿病中的肝线粒体和胰岛素抵抗
基本信息
- 批准号:8402120
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-04-01 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAffectAgeBehavior TherapyBody Weight decreasedCaloric RestrictionChronicCirrhosisCombined Modality TherapyDevelopmentDiabetes MellitusDietDiseaseEffectivenessEuglycemic ClampingExerciseFatty LiverFunctional disorderFutureGeneral PopulationGlucose ClampGoalsHealth PersonnelHealth ProfessionalHealthcare SystemsHepaticHigh PrevalenceHumanHyperglycemiaHyperphagiaHypoglycemiaInbred OLETF RatsIncidenceIndividualInsulin ResistanceInterventionLeadLinkLipidsLiverLiver MitochondriaLiver diseasesMetforminMitochondriaModelingMorbidity - disease rateNon-Insulin-Dependent Diabetes MellitusObesityOralPathogenesisPatientsPeripheralPharmaceutical PreparationsPopulationPrevalenceResistance developmentRodent ModelRoleScientistSecondary toTherapeuticTranscriptional RegulationTransplantation ConditioningVeteransWorkdiabeticglucose outputin vivoinsightinsulin sensitivityliver transplantationmitochondrial dysfunctionmortalitynon-alcoholic fatty livernoveloxidationpreventpublic health relevancesedentarytherapeutic target
项目摘要
DESCRIPTION (provided by applicant):
Nonalcoholic fatty liver disease (NAFLD) is a chronic, progressive liver disease that affects 30% of all US adults. NAFLD is strongly linked to type 2 diabetes, with an estimated 80% of type 2 diabetics having NAFLD. Unfortunately, the Veteran population has a significantly higher prevalence of diabetes than the general population (20-25% vs. 6-8%), and, therefore, it would be expected to have a similarly higher prevalence of NAFLD. Because NAFLD leads to a significant number of patients with cirrhosis and need for liver transplantation, this condition is an important issue for the VA healthcare system. Despite the strong association between NAFLD and type 2 diabetes, a unifying pathophysiology remains poorly understood. The overall hypothesis of this proposal is that hepatic lipid intermediate/metabolite accumulation and hepatic insulin resistance develops due to hepatic mitochondrial dysfunction, which leads to dysregulated hepatic glucose output and ultimately development of type 2 diabetes. In addition, targeting hepatic mitochondrial dysfunction and hepatic insulin resistance with lifestyle modifications and/or pharmacological interventions will effectively treat NAFLD and type 2 diabetes. We will conduct studies in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat, a well characterized rodent model of hyperphagia-induced obesity, NAFLD, and type 2 diabetes to examine the following specific aims. 1) Determine whether hepatic insulin resistance associated with NAFLD develops secondary to mitochondrial dysfunction and is a significant contributing factor in the development of type 2 diabetes. 2) Determine the effectiveness of daily exercise vs. caloric restriction (with and without metformin) in the treatment of NAFLD and type 2 diabetes. For Aim 1, OLETF rats will be studied at different ages throughout the spectrum of pre-insulin resistance, insulin resistance, and development of frank type 2 diabetes. For Aim 2, OLETF rats will be treated with exercise, caloric restriction, metformin, or combination therapies. The studies will employ in-vivo hyperinsulinemic-euglycemic clamps to assess systemic and hepatic insulin sensitivity and thorough examinations of hepatic mitochondrial function/content and lipid intermediate/metabolites accumulation. This project is extremely novel as it will examine the role of hepatic mitochondrial dysfunction and hepatic insulin resistance throughout the initiation, development, and progression of systemic insulin resistance and type 2 diabetes. In addition, it will comprehensively examine the effectiveness of lifestyle modifications and pharmacological interventions in the treatment of NAFLD and type 2 diabetes. These studies will provide future insight into reducing the incidence of type 2 diabetes and NAFLD in our Veteran population.
描述(由申请人提供):
非酒精性脂肪肝 (NAFLD) 是一种慢性进行性肝病,影响 30% 的美国成年人。 NAFLD 与 2 型糖尿病密切相关,估计 80% 的 2 型糖尿病患者患有 NAFLD。不幸的是,退伍军人群体的糖尿病患病率明显高于普通人群(20-25% vs. 6-8%),因此,预计其 NAFLD 患病率也同样较高。由于 NAFLD 导致大量患者出现肝硬化并需要肝移植,因此这种情况对于 VA 医疗保健系统来说是一个重要问题。尽管 NAFLD 与 2 型糖尿病之间存在密切关联,但其统一的病理生理学仍然知之甚少。该提议的总体假设是,肝脂质中间体/代谢物积累和肝胰岛素抵抗是由于肝线粒体功能障碍而产生的,这导致肝葡萄糖输出失调并最终发展为2型糖尿病。此外,通过改变生活方式和/或药物干预来针对肝线粒体功能障碍和肝胰岛素抵抗,将有效治疗 NAFLD 和 2 型糖尿病。我们将在 Otsuka Long-Evans Tokushima Fatty (OLETF) 大鼠(OLETF)中进行研究,这是一种经过充分表征的啮齿动物模型,患有过度进食引起的肥胖、NAFLD 和 2 型糖尿病,以检查以下具体目标。 1) 确定与 NAFLD 相关的肝脏胰岛素抵抗是否继发于线粒体功能障碍,并且是 2 型糖尿病发生的重要因素。 2) 确定每日运动与热量限制(使用或不使用二甲双胍)在 NAFLD 和 2 型糖尿病治疗中的有效性。对于目标 1,将对不同年龄的 OLETF 大鼠进行研究,涵盖胰岛素抵抗前、胰岛素抵抗和 2 型糖尿病的发展。对于目标 2,OLETF 大鼠将接受运动、热量限制、二甲双胍或联合疗法的治疗。这些研究将采用体内高胰岛素-正常血糖钳来评估全身和肝脏胰岛素敏感性,并彻底检查肝线粒体功能/含量和脂质中间体/代谢物积累。该项目非常新颖,因为它将研究肝线粒体功能障碍和肝胰岛素抵抗在全身胰岛素抵抗和 2 型糖尿病的起始、发展和进展过程中的作用。此外,还将全面考察生活方式改变和药物干预治疗 NAFLD 和 2 型糖尿病的有效性。这些研究将为未来降低退伍军人群体中 2 型糖尿病和 NAFLD 的发病率提供见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RANDY SCOTT RECTOR其他文献
RANDY SCOTT RECTOR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RANDY SCOTT RECTOR', 18)}}的其他基金
Hepatic eNOS and Mitochondrial Function in NASH
NASH 中的肝脏 eNOS 和线粒体功能
- 批准号:
9346872 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Hepatic eNOS and Mitochondrial Function in NASH
NASH 中的肝脏 eNOS 和线粒体功能
- 批准号:
9898232 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Hepatic Mitochondria and Insulin Resistance in Fatty Liver and Type 2 Diabetes
脂肪肝和 2 型糖尿病中的肝线粒体和胰岛素抵抗
- 批准号:
8244949 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Hepatic Mitochondria and Insulin Resistance in Fatty Liver and Type 2 Diabetes
脂肪肝和 2 型糖尿病中的肝线粒体和胰岛素抵抗
- 批准号:
8795676 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Hepatic Mitochondria and Insulin Resistance in Fatty Liver and Type 2 Diabetes
脂肪肝和 2 型糖尿病中的肝线粒体和胰岛素抵抗
- 批准号:
8698282 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Hepatic Mitochondria and Insulin Resistance in Fatty Liver and Type 2 Diabetes
脂肪肝和 2 型糖尿病中的肝线粒体和胰岛素抵抗
- 批准号:
8141607 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Exercise, mitochondrial function, and fatty acid oxidation in fatty liver disease
脂肪肝疾病中的运动、线粒体功能和脂肪酸氧化
- 批准号:
7613590 - 财政年份:2008
- 资助金额:
-- - 项目类别:
Exercise, mitochondrial function, and fatty acid oxidation in fatty liver disease
脂肪肝疾病中的运动、线粒体功能和脂肪酸氧化
- 批准号:
7697934 - 财政年份:2008
- 资助金额:
-- - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
-- - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
-- - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
-- - 项目类别:
Miscellaneous Programs